The United Kingdom’s Medicines Control Agency has approved human testing for the experimental modified vaccinia Ankara-strain (MVA) vaccine candidate funded by the International AIDS Vaccine Initiative. The candidate is targeted for use in Africa, and the first part of the vaccine entered trials in England this August. The vaccine candidates are the result of work between Andrew McMichael of Oxford University and Professor J.J. Bwayo of the University of Nairobi in Kenya.

Source: CDC HIV/STD/TB Prevention News Update